Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1AKris M. White, Adolfo García‐Sastre, Soner Yildiz et al.|Science|2021Cited by 364
Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored VaccinesLynda Coughlan|Frontiers in Immunology|2020Cited by 133